Sponsor:

National Institute of Mental Health

The project focused on individualizing PTSD care across key parameters: choice of treatment, combined psychotherapy and pharmacological treatment, and the presence of co-occurring major depression (MDD). The results of the proposed research will inform clinicians about clients’ treatment preferences, the relative short- and long-term effectiveness of combined PE and sertraline, provide information about more complex patients and when “more or less” treatment is desired and/or needed, and provide contextual information about biological, psychosocial, and process markers of therapeutic change.